Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001718983 | SCV000723916 | benign | not provided | 2021-02-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001718983 | SCV002378016 | benign | not provided | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002456368 | SCV002738831 | benign | Cardiovascular phenotype | 2019-04-15 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004525984 | SCV005039601 | uncertain significance | not specified | 2024-03-11 | criteria provided, single submitter | clinical testing |